ArticleEnvironmental analysis, health and toxicology2025
Big data and AI: Potential and challenges for digital transformation in toxicology.
Article in Environmental analysis, health and toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Advancing the Discovery of Emerging Contaminants: A Leap in Technology and Data.Environmental science & technology · 2026Review
- Four Decades of Environmental Analysis, Health and Toxicology.Environmental analysis, health and toxicology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Toxicology has evolved from an observational science to predictive science, driven by advances in computational methods and large-scale data generation. Advances in computing power and the rapid accumulation of toxicological big data have opened new opportunities to modernize chemical risk assessment through artificial intelligence (AI). This study explores the current status of toxicity databases and key methodologies of AI such as machine learning, deep learning, and large language models. The study further examines representative case studies, which leverage AI-based toxicity prediction models in chemical prioritization and others. Despite the advancements, critical challenges remain, including the limited availability of high-quality, homogeneous datasets and the black-box nature of AI models, which hinder regulatory acceptance. To address these issues, this study emphasizes the need for explainable AI and the integration of the adverse outcome pathway framework to enhance model interpretability. By outlining future research directions and advocating for transparent, reproducible AI models, this study contributes to advancing regulatory science, chemical safety assessment, and the broader adoption of AI as new approach methodologies (NAMs) for next generation risk assessment (NGRA).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.